ANTIBODIES AGAINST THE SARS-COV-2 SPIKE GLYCOPROTEIN AND ANTIGEN-BINDING FRAGMENTS
CY1126023T1Undetermined Publication Date: 2026-07-31REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100186T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-06-25
- Filing Date
- 2023-04-10
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2043-04-10
Abstract
The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to a coronavirus spike protein and methods of using such antibodies and fragments for the treatment or prevention of viral infections (e.g., coronavirus infections).
Need to check novelty before this filing date? Find Prior Art